Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lori Robbins

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Gastroenterology Reports|August 16, 2015
Hepatitis B: Working Towards a CureBianca W Chang, Aung Kaung, Lori Robbins, et al.
World Journal of Gastroenterology|November 17, 2017
Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patientsDaniel Lew, Soon Man Yoon, Xiaofei Yan, et al.
Digestive Diseases and Sciences|March 15, 2020
Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative ColitisGaurav Syal, Lori Robbins, Amir Kashani, et al.
Journal of Crohn'S & Colitis|July 29, 2016
Outcomes with Anti-Tumour Necrosis Factor-Alpha Therapy and Serology in Patients with Denovo Crohn's Disease After Ileal Pouch Anal AnastomosisLori Robbins, Karen Zaghiyan, Gil Melmed, et al.
Scientific Reports|November 29, 2017
CSA13 inhibits colitis-associated intestinal fibrosis via a formyl peptide receptor like-1 mediated HMG-CoA reductase pathwayChunlan Xu, Sally Ghali, Jiani Wang, et al.
Gastroenterology|March 15, 2024
Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel DiseaseMichelle Khrom, Millie Long, Shishir Dube, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Gastroenterology Reports|August 16, 2015
Hepatitis B: Working Towards a CureBianca W Chang, Aung Kaung, Lori Robbins, et al.
World Journal of Gastroenterology|November 17, 2017
Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patientsDaniel Lew, Soon Man Yoon, Xiaofei Yan, et al.
Digestive Diseases and Sciences|March 15, 2020
Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative ColitisGaurav Syal, Lori Robbins, Amir Kashani, et al.
Journal of Crohn'S & Colitis|July 29, 2016
Outcomes with Anti-Tumour Necrosis Factor-Alpha Therapy and Serology in Patients with Denovo Crohn's Disease After Ileal Pouch Anal AnastomosisLori Robbins, Karen Zaghiyan, Gil Melmed, et al.
Scientific Reports|November 29, 2017
CSA13 inhibits colitis-associated intestinal fibrosis via a formyl peptide receptor like-1 mediated HMG-CoA reductase pathwayChunlan Xu, Sally Ghali, Jiani Wang, et al.
Gastroenterology|March 15, 2024
Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel DiseaseMichelle Khrom, Millie Long, Shishir Dube, et al.
Pageof 1